Skip to content

CHINA HEALTH INDUSTRIES HOLDINGS, INC.: 10-Q filed 2018-02-09

What CHINA HEALTH INDUSTRIES HOLDINGS, INC. reported in its quarterly report filed 2018-02-09 (fiscal Q2 2018): 37 published measures, 106 facts as tagged in accession 0001062993-18-000524.

This filing

Form
10-Q (quarterly report)
Filed
2018-02-09
Fiscal period
fiscal Q2 2018
Accession
0001062993-18-000524 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CHINA HEALTH INDUSTRIES HOLDINGS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2017-12-3143,385,203USD
At 2017-06-3041,702,978USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2017-12-3135,888,034USD
At 2017-06-3034,707,856USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2017-12-3132,594,709USD
At 2017-06-3021,197,448USD
At 2016-12-3120,275,994USD
At 2016-06-3029,783,152USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-10-01 to 2017-12-31-110,573USD92
2017-07-01 to 2017-12-31-289,743USD184
2016-10-01 to 2016-12-311,269,709USD92
2016-07-01 to 2016-12-311,293,732USD184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2017-07-01 to 2017-12-311,783,237USD184
2016-07-01 to 2016-12-31-785,019USD184

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2017-07-01 to 2017-12-31-15,354USD184
2016-07-01 to 2016-12-310USD184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2017-07-01 to 2017-12-319,935,364USD184
2016-07-01 to 2016-12-31-7,288,676USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2017-12-3133,928,942USD
At 2017-06-3034,218,685USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2017-10-01 to 2017-12-3165,539,737shares92
2017-07-01 to 2017-12-3165,539,737shares184
2016-10-01 to 2016-12-3165,812,020shares92
2016-07-01 to 2016-12-3165,812,020shares184

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2017-10-01 to 2017-12-31-0.0027USD/shares92
2017-07-01 to 2017-12-31-0.0044USD/shares184
2016-10-01 to 2016-12-310.0193USD/shares92
2016-07-01 to 2016-12-310.0197USD/shares184

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2017-10-01 to 2017-12-3189,388USD92
2017-07-01 to 2017-12-31129,040USD184
2016-10-01 to 2016-12-31439,620USD92
2016-07-01 to 2016-12-31493,650USD184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2017-12-313,645,811USD
At 2017-06-303,694,304USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2017-07-01 to 2017-12-310USD184
2016-07-01 to 2016-12-310USD184

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2017-10-01 to 2017-12-31-36,393USD92
2017-07-01 to 2017-12-31-199,765USD184
2016-10-01 to 2016-12-31141,909USD92
2016-07-01 to 2016-12-31-12,347USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2017-12-3135,176,970USD
At 2017-06-3033,526,244USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2017-10-01 to 2017-12-3125,062USD92
2017-07-01 to 2017-12-3148,402USD184
2016-10-01 to 2016-12-3121,051USD92
2016-07-01 to 2016-12-3142,737USD184

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2017-12-317,497,169USD
At 2017-06-306,995,122USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2017-12-313,678,469USD
At 2017-06-303,642,544USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2017-12-311,531,075USD
At 2017-06-301,625,695USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2017-10-01 to 2017-12-31692,356USD92
2017-07-01 to 2017-12-311,392,062USD184
2016-10-01 to 2016-12-31570,550USD92
2016-07-01 to 2016-12-311,149,689USD184

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2017-12-31477,074USD
At 2017-06-30454,468USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2017-10-01 to 2017-12-31655,963USD92
2017-07-01 to 2017-12-311,192,297USD184
2016-10-01 to 2016-12-31712,459USD92
2016-07-01 to 2016-12-311,137,342USD184

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2017-10-01 to 2017-12-31625,606USD92
2017-07-01 to 2017-12-311,183,458USD184
2016-10-01 to 2016-12-31327,091USD92
2016-07-01 to 2016-12-31757,355USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2017-12-3165,539,737shares
At 2017-06-3065,539,737shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2017-12-311,391,872USD
At 2017-06-30-78,049USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2017-12-3135,888,034USD
At 2017-06-3034,707,856USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2017-12-312,497,393USD
At 2017-06-302,225,334USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2017-12-313,678,469USD
At 2017-06-303,642,544USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2017-10-01 to 2017-12-31-21,185USD92
2017-07-01 to 2017-12-31-160,703USD184
2016-10-01 to 2016-12-311,709,329USD92
2016-07-01 to 2016-12-311,787,382USD184

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2017-10-01 to 2017-12-31679,241USD92
2017-07-01 to 2017-12-312,745,915USD184
2016-10-01 to 2016-12-31466,207USD92
2016-07-01 to 2016-12-31372,519USD184

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2017-10-01 to 2017-12-31-179,170USD92
2017-07-01 to 2017-12-31-289,743USD184
2016-10-01 to 2016-12-311,269,709USD92
2016-07-01 to 2016-12-311,293,732USD184

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2017-07-01 to 2017-12-31289,596USD184
2016-07-01 to 2016-12-31520,038USD184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2017-10-01 to 2017-12-3115,208USD92
2017-07-01 to 2017-12-3139,062USD184
2016-10-01 to 2016-12-311,567,420USD92
2016-07-01 to 2016-12-311,799,729USD184

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2017-10-01 to 2017-12-3189,388USD92
2017-07-01 to 2017-12-31129,040USD184
2016-10-01 to 2016-12-31439,620USD92
2016-07-01 to 2016-12-31493,650USD184

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2017-10-01 to 2017-12-310USD92
2017-07-01 to 2017-12-31-348USD184
2016-10-01 to 2016-12-310USD92
2016-07-01 to 2016-12-310USD184

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2017-07-01 to 2017-12-31-157,408USD184
2016-07-01 to 2016-12-31528,536USD184

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2017-07-01 to 2017-12-31-57,255USD184
2016-07-01 to 2016-12-3176,086USD184

Inspect the source

Entity
CHINA HEALTH INDUSTRIES HOLDINGS, INC. / CIK 0001309057
Captured
SEC response SHA-256
93829603b3c881951d34b2b4bb637d2441d1808eaea70ed12e10811c21d923de

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001309057.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))